Literature DB >> 32289162

Passively transferred IgG enhances humoral immunity to a red blood cell alloantigen in mice.

David R Gruber1, Amanda L Richards1, Heather L Howie2,3, Ariel M Hay2, Jenna N Lebedev1, Xiaohong Wang1, James C Zimring2,3, Krystalyn E Hudson4.   

Abstract

Antibodies are typically thought of as the endpoint of humoral immunity that occur as the result of an adaptive immune response. However, affinity-matured antibodies can be present at the initiation of a new immune response, most commonly because of passive administration as a medical therapy. The current paradigm is that immunoglobulin M (IgM), IgA, and IgE enhance subsequent humoral immunity. In contrast, IgG has a "dual effect" in which it enhances responses to soluble antigens but suppresses responses to antigens on red blood cells (RBCs) (eg, immunoprophylaxis with anti-RhD). Here, we report a system in which passive antibody to an RBC antigen promotes a robust cellular immune response leading to endogenous CD4+ T-cell activation, germinal center formation, antibody secretion, and immunological memory. The mechanism requires ligation of Fcγ receptors on a specific subset of dendritic cells that results in CD4+ T-cell activation and expansion. Moreover, antibodies cross-enhance responses to a third-party antigen, but only if it is expressed on the same RBC as the antigen recognized by the antibody. Importantly, these observations were IgG subtype specific. Thus, these findings demonstrate that antibodies to RBC alloantigens can enhance humoral immunity in an IgG subtype-specific fashion and provide mechanistic elucidation of the enhancing effects.
© 2020 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32289162      PMCID: PMC7160277          DOI: 10.1182/bloodadvances.2019001299

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  32 in total

Review 1.  Regulation of antibody responses via antibodies, complement, and Fc receptors.

Authors:  B Heyman
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  FcgammaRIIB in IgG-mediated suppression of antibody responses: different impact in vivo and in vitro.

Authors:  M C Karlsson; A Getahun; B Heyman
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

3.  Anti-KEL sera prevents alloimmunization to transfused KEL RBCs in a murine model.

Authors:  Sean R Stowell; C Maridith Arthur; Kathryn R Girard-Pierce; Harold C Sullivan; Manjula Santhanakrishnan; Prabitha Natarajan; Seema R Patel; Christopher A Tormey; James C Zimring; Jeanne E Hendrickson
Journal:  Haematologica       Date:  2015-07-16       Impact factor: 9.941

4.  IgG-Mediated Immune Suppression to Erythrocytes by Polyclonal Antibodies Can Occur in the Absence of Activating or Inhibitory Fcγ Receptors in a Full Mouse Model.

Authors:  Lidice Bernardo; Honghui Yu; Alaa Amash; James C Zimring; Alan H Lazarus
Journal:  J Immunol       Date:  2015-07-17       Impact factor: 5.422

5.  Regulation of the immune response. VI. Inability of F(ab') 2 antibody to terminate established immune responses and its ability to interfere with IgG antibody-mediated immunosuppression.

Authors:  P L Chan; N R Sinclair
Journal:  Immunology       Date:  1973-02       Impact factor: 7.397

6.  Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells.

Authors:  Jeanne E Hendrickson; Maxime Desmarets; Seema S Deshpande; Traci E Chadwick; Christopher D Hillyer; John D Roback; James C Zimring
Journal:  Transfusion       Date:  2006-09       Impact factor: 3.157

7.  Generation of transgenic mice with antithetical KEL1 and KEL2 human blood group antigens on red blood cells.

Authors:  Nicole H Smith; Kate L Henry; Chantel M Cadwell; Ashley Bennett; Jeanne E Hendrickson; Tom Frame; James C Zimring
Journal:  Transfusion       Date:  2012-04-12       Impact factor: 3.157

8.  IgG-mediated immunosuppression is not dependent on erythrocyte clearance or immunological evasion: implications for the mechanism of action of anti-D in the prevention of haemolytic disease of the newborn?

Authors:  Davor Brinc; Hoang Le-Tien; Andrew R Crow; John Freedman; Alan H Lazarus
Journal:  Br J Haematol       Date:  2007-10       Impact factor: 6.998

9.  Competition of 19S and 7S antigen receptors in the regulation of the primary immune response.

Authors:  C Henry; N K Jerne
Journal:  J Exp Med       Date:  1968-07-01       Impact factor: 14.307

10.  The Role of the Immunological Synapse in Differential Effects of APC Subsets in Alloimmunization to Fresh, Non-stored RBCs.

Authors:  Amanda L Richards; Kathryn Sheldon; Xiaoping Wu; David R Gruber; Krystalyn E Hudson
Journal:  Front Immunol       Date:  2018-10-05       Impact factor: 7.561

View more
  6 in total

1.  Antihypertensive and Immunomodulatory Effects of Defatted Corn Germ Hydrolysates: An in vivo Study.

Authors:  Jiaqi Zhu; Jing Li; Yiting Guo; Janet Quaisie; Chen Hong; Haile Ma
Journal:  Front Nutr       Date:  2021-05-24

2.  Antibodies to Low-Copy Number RBC Alloantigen Convert a Tolerogenic Stimulus to an Immunogenic Stimulus in Mice.

Authors:  Arijita Jash; Chomkan Usaneerungrueng; Heather L Howie; Annie Qiu; Chance John Luckey; James C Zimring; Krystalyn E Hudson
Journal:  Front Immunol       Date:  2021-03-12       Impact factor: 7.561

3.  A New Murine Model of Primary Autoimmune Hemolytic Anemia (AIHA).

Authors:  Flavia Dei Zotti; Annie Qiu; Francesca La Carpia; Chiara Moriconi; Krystalyn E Hudson
Journal:  Front Immunol       Date:  2021-11-15       Impact factor: 7.561

4.  FcγRIV is required for IgG2c mediated enhancement of RBC alloimmunization.

Authors:  Annie Qiu; Anabel Miller; Flavia Dei Zotti; Manjula Santhanakrishnan; Jeanne E Hendrickson; Maria Tredicine; Sean R Stowell; Chance John Luckey; James C Zimring; Krystalyn E Hudson
Journal:  Front Immunol       Date:  2022-09-13       Impact factor: 8.786

5.  Complement Plays a Critical Role in Inflammation-Induced Immunoprophylaxis Failure in Mice.

Authors:  Vicente Escamilla-Rivera; Manjula Santhanakrishnan; Jingchun Liu; David R Gibb; James E Forsmo; Ellen F Foxman; Stephanie C Eisenbarth; C John Luckey; James C Zimring; Krystalyn E Hudson; Sean R Stowell; Jeanne E Hendrickson
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 8.786

6.  IgG Subclass Determines Suppression Versus Enhancement of Humoral Alloimmunity to Kell RBC Antigens in Mice.

Authors:  Paurvi Shinde; Heather L Howie; Tamara C Stegmann; Ariel M Hay; Hayley R Waterman; Zoltan Szittner; Arthur E H Bentlage; Linda Kapp; Suzanne N Lissenberg-Thunnissen; Gillian Dekkers; Richard B M Schasfoort; Sarah J Ratcliffe; Mark E Smolkin; Gestur Vidarsson; C Ellen van der Schoot; Krystalyn E Hudson; James C Zimring
Journal:  Front Immunol       Date:  2020-07-16       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.